NICE Says No To Covering Bristol’s Orencia For Rheumatoid Arthritis
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol will file an appeal to the decision within 10 working days, the firm tells “The Pink Sheet” DAILY.